← All companies

TLSI

TriSalus Life Sciences, Inc.

TLSIW Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$0.84

+0.07 +9.09%

Key statistics

from XBRL data in SEC filings

Market cap

$51.6M

Revenue (TTM)

$44.9M

Net income (TTM)

-$27.3M

EPS (TTM)

$-1.42

P/E ratio

—

Dividend yield

—

Free cash flow

-$18.9M

Cash

$56.6M

Total assets

$71.0M

Gross margin

85.1%

52-week range

$0.44 – $2.69

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results May 14, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Director or officer change Apr 29, 2026 8-K Director or officer change; Regulation FD disclosure Apr 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Entered a material agreement; Other events Feb 20, 2026 8-K Director or officer change; Regulation FD disclosure Feb 9, 2026 8-K Results of operations (earnings release) Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Director or officer change Oct 1, 2025 8-K Director or officer change Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results; Other events Jul 24, 2025 8-K Other events Jun 23, 2025 8-K Shareholder vote results Jun 16, 2025 8-K Director or officer change; Other events May 30, 2025 10-K/A Fiscal year ended 2024-12-31 May 30, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure Apr 30, 2025 8-K Director or officer change Apr 23, 2025 8-K Director or officer change Apr 17, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Director or officer change Feb 25, 2025 8-K Took on a direct financial obligation; Unregistered sale of equity Feb 19, 2025 8-K Results of operations (earnings release) Feb 3, 2025 8-K Director or officer change Jan 31, 2025 8-K Results of operations (earnings release) Jan 23, 2025 8-K Director or officer change Jan 8, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Director or officer change Nov 1, 2024 8-K Results of operations (earnings release); Shareholder vote results Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Other events Jul 1, 2024